Compare Royal Caribbean Cruises Ltd (RCL) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Caribbean Cruises Ltd vs Stryker Corporation — how do they compare? Royal Caribbean Cruises Ltd trades at $260.05 (market cap $70.74B), while Stryker Corporation trades at $277.44 (market cap $105.63B). The key difference: Stryker Corporation is the larger of the two by market cap, and Royal Caribbean Cruises Ltd pays the higher dividend (2.27%). Which is the better fit depends on your goals.
| RCL | SYK | |
|---|---|---|
Market Cap | $70.74B | $105.63B |
Sector | Consumer Cyclical | Technology |
52-Week High | $350.23 | $388.79 |
52-Week Low | $246.71 | $275.39 |
Enterprise Value | $93.38B | $117.10B |
Dividend Yield | 2.27% | 1.28% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $264.5, down 0.26% on the day, with a bearish technical signal from moving averages but bullish oscillators. The stock shows strong fundamentals with Q2 2026 EPS beating expectations at $4.21 versus $3.98, and robust profitability margins including a 23.54% net income margin. Recent news highlights dividend declarations and institutional buying interest, though oil price increases pose near-term headwinds for cruise operators.
The outlook remains positive with analyst consensus price target of $367.83 implying significant upside, supported by earnings growth and debt reduction trends. Key risks include fuel cost volatility from rising oil prices and macroeconomic sensitivity, but institutional accumulation and strong cash flows provide a solid foundation for long-term investors.
Stryker (SYK) is trading at $276.43, down 8.81% over 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported mixed quarterly earnings, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. Strong fundamentals include a net income margin of 14.43% and ROE of 16.51%, though valuation ratios like a P/E of 28.65 are elevated. Recent news includes a securities fraud investigation announcement and the launch of an FDA-cleared surgical app for Apple Vision Pro.
The outlook for SYK is supported by solid profitability and growth initiatives like acquisitions and product launches, but near-term risks include the fraud investigation and competitive pressures. Analyst consensus is strongly bullish with a $376 price target, suggesting significant upside potential if the company navigates current challenges successfully.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
